Vimarsana
Biggest News Aggregation in the World

Page 36 - Trinity Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trinity Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trinity Biotech Today - Breaking & Trending Today

Trinity Biotech Announces the Successful Closing of the $30 Million Sale of its Life Sciences Supply Business to Biosynth - Vimarsana News

Trinity Biotech Announces the Successful Closing of the $30 Million Sale of its Life Sciences Supply Business to Biosynth

DUBLIN, Ireland, April 27, 2023 -- Trinity Biotech plc , a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today announced that it... | April 27, 2023

Trinity Biotech : Amended And Restated Credit Agreement - Form 6-K - Vimarsana News

Trinity Biotech : Amended And Restated Credit Agreement - Form 6-K

Exhibit 4.10.1 First Amendment to Amended and Restated Credit Agreement and Guaranty This First Amendment... | June 18, 2023

Enteric Disease Testing Market to Reach $5.3 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research - Vimarsana News

Enteric Disease Testing Market to Reach $5.3 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research

/PRNewswire/ -- Allied Market Research published a report, titled, "Enteric Disease Testing Market By Product Type (Reagents and Consumables, Equipment), By...

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement - Vimarsana News

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement

DUBLIN, Ireland, April 24, 2023 -- Trinity Biotech plc , a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today announced that on... | June 18, 2023

Trinity Biotech sells life sciences supply firm to Biosynth for $30m - Vimarsana News

Trinity Biotech sells life sciences supply firm to Biosynth for $30m

Trinity Biotech said life sciences supply is no longer a core part of its strategy and will use the sale proceeds to significantly reduce its debt. Irish…

Source: biztoc.com
Related Topics:
Trinity BiotechReaking News